Created after the first edition of the I-Teams programme of the Translationnal Accelerator UNIGE/ Inartis, FluoSphera develops a unique technology platform with the goal to predict the effects of drug candidates much better by mimicking the communications between multiple human organs. The start-up has completed a world-class acceleration program in New York and attracted further renowned investors.
